Acadian Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-6,328
| Closed | -$253K | – | 1885 |
|
2024
Q3 | $253K | Buy |
+6,328
| New | +$253K | ﹤0.01% | 1284 |
|
2024
Q2 | – | Sell |
-5,891
| Closed | -$255K | – | 1829 |
|
2024
Q1 | $255K | Buy |
+5,891
| New | +$255K | ﹤0.01% | 1146 |
|
2023
Q2 | – | Sell |
-3,073
| Closed | -$109K | – | 1820 |
|
2023
Q1 | $109K | Buy |
+3,073
| New | +$109K | ﹤0.01% | 1379 |
|
2022
Q4 | – | Sell |
-20,390
| Closed | -$898K | – | 1845 |
|
2022
Q3 | $898K | Buy |
+20,390
| New | +$898K | ﹤0.01% | 836 |
|
2021
Q2 | – | Sell |
-2,378
| Closed | -$107K | – | 2099 |
|
2021
Q1 | $107K | Sell |
2,378
-32,026
| -93% | -$1.44M | ﹤0.01% | 1659 |
|
2020
Q4 | $1.95M | Buy |
34,404
+9,247
| +37% | +$523K | 0.01% | 764 |
|
2020
Q3 | $1.19M | Sell |
25,157
-33,366
| -57% | -$1.58M | 0.01% | 843 |
|
2020
Q2 | $3.45M | Buy |
58,523
+57,420
| +5,206% | +$3.39M | 0.01% | 569 |
|
2020
Q1 | $52K | Sell |
1,103
-1,907
| -63% | -$89.9K | ﹤0.01% | 1495 |
|
2019
Q4 | $182K | Buy |
+3,010
| New | +$182K | ﹤0.01% | 1315 |
|
2019
Q3 | – | Sell |
-963
| Closed | -$62K | – | 1936 |
|
2019
Q2 | $62K | Buy |
963
+24
| +3% | +$1.55K | ﹤0.01% | 1441 |
|
2019
Q1 | $76K | Sell |
939
-2,889
| -75% | -$234K | ﹤0.01% | 1584 |
|
2018
Q4 | $207K | Buy |
3,828
+3,670
| +2,323% | +$198K | ﹤0.01% | 1111 |
|
2018
Q3 | $8K | Hold |
158
| – | – | ﹤0.01% | 1569 |
|
2018
Q2 | $7K | Buy |
158
+110
| +229% | +$4.87K | ﹤0.01% | 1611 |
|
2018
Q1 | $2K | Sell |
48
-2,781
| -98% | -$116K | ﹤0.01% | 1645 |
|
2017
Q4 | $143K | Sell |
2,829
-551
| -16% | -$27.9K | ﹤0.01% | 1020 |
|
2017
Q3 | $171K | Buy |
+3,380
| New | +$171K | ﹤0.01% | 942 |
|
2017
Q2 | – | Sell |
-143
| Closed | -$6K | – | 1507 |
|
2017
Q1 | $6K | Buy |
+143
| New | +$6K | ﹤0.01% | 1460 |
|
2016
Q1 | – | Sell |
-134
| Closed | -$8K | – | 1415 |
|
2015
Q4 | $8K | Sell |
134
-76
| -36% | -$4.54K | ﹤0.01% | 1264 |
|
2015
Q3 | $9K | Buy |
+210
| New | +$9K | ﹤0.01% | 1146 |
|